Trials / Conditions / Adebrelimab (SHR-1316)
Adebrelimab (SHR-1316)
4 registered clinical trials studyying Adebrelimab (SHR-1316) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC NCT07035392 | Zhangzhou Municipal Hospital | Phase 2 |
| Recruiting | Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACH NCT06607276 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Recruiting | A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastr NCT06506292 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcit NCT06454448 | Tianjin Medical University Cancer Institute and Hospital | Phase 1 / Phase 2 |